Fight Aging! Newsletter, December 4th 2017
In this study, we integrated atomic force microscopy (AFM) and molecular approaches to determine whether increased stiffness of aortic VSMCs in hypertensive rats is ROCK-dependent, and whether the anti-hypertensive effect of ROCK inhibitors contributes to the reduction of aortic stiffness via changing VSMC mechanical properties.
Despite a widely held belief that aortic stiffening is associated with changes in extracellular matrix proteins and endothelial dysfunction, our recent studies demonstrated that intrinsic stiffening of aortic VSMCs, independent of VSMC proliferation and migration, is an important contributor to aortic wall stiffening both in hypertensive and aged animals. The present study demonstrates for the first time that ROCK is a novel mediator of aortic VSMC stiffening in hypertension, which has never been described previously. Furthermore, our study also indicated that attenuation of aortic VSMC stiffening by pharmacological inhibition can serve as a promising therapeutic target to correct aortic stiffening not only in hypertension, but also in other age-related vascular diseases.
Linking RAGE, DNA Damage, Cellular Senescence, and Reversible Fibrosis
https://www.fightaging.org/archives/2017/11/linking-rage-dna-damage-cellular-senescence-and-reversible-fibrosis/
Researchers here find that loss of RAGE in mice produces accelerated fibrosis that is reversible if RAGE is restored. It is a little early in this line of research to be ent...
Source: Fight Aging! - Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
More News: Academia | Alzheimer's | Arrhythmia | Back Pain | Biochemistry | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cancer Therapy | Cardiology | Cardiovascular | Chronic Pain | Clinical Trials | Conferences | Contracts | Databases & Libraries | Dementia | Dermatology | Diabetes | Diets | Disability | Eating Disorders & Weight Management | Endocrinology | Environmental Health | Epidemiology | European Medicines Agency (EMA) | Expenditures | Fortamet | Funding | Fundraising | Gastroschisis Repair | Genetics | Heart | Heart Attack | Heart Failure | Heart Transplant | Hospitals | Hypertension | Immunotherapy | Information Technology | Jobs | Kidney Transplant | Kidney Transplantation | Laboratory Medicine | Learning | Lung Transplant | Medical Devices | Men | Menopause | Metformin | Mitochondrial Disease | Molecular Biology | Neurology | Neuroscience | Nutrition | Obesity | Organ Donation | Orthopaedics | Pain | Partnerships | Pathology | Research | Russia Health | Science | Skin | Smokers | Sports Medicine | Statistics | Stem Cell Therapy | Stem Cells | Study | Substance Abuse | Toxicology | Training | Transplants | Universities & Medical Training | Urology & Nephrology | Weight Loss | Women